KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Non-cash Items (2020 - 2024)

GoodRx Holdings' Non-cash Items history spans 5 years, with the latest figure at $4.4 million for Q4 2024.

  • For Q4 2024, Non-cash Items rose 21363.41% year-over-year to $4.4 million; the TTM value through Dec 2024 reached $4.4 million, up 21363.41%, while the annual FY2024 figure was $4.4 million, 21363.41% up from the prior year.
  • Non-cash Items for Q4 2024 was $4.4 million at GoodRx Holdings, up from $20500.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $680.5 million in Q1 2021 and bottomed at $20500.0 in Q4 2023.
  • The 5-year median for Non-cash Items is $44.0 million (2020), against an average of $163.9 million.
  • The largest annual shift saw Non-cash Items tumbled 99.92% in 2023 before it surged 21363.41% in 2024.
  • A 5-year view of Non-cash Items shows it stood at $341.9 million in 2020, then changed by 0.0% to $341.9 million in 2021, then crashed by 92.72% to $24.9 million in 2022, then crashed by 99.92% to $20500.0 in 2023, then soared by 21363.41% to $4.4 million in 2024.
  • Per Business Quant, the three most recent readings for GDRX's Non-cash Items are $4.4 million (Q4 2024), $20500.0 (Q4 2023), and $24.9 million (Q4 2022).